Feedback / Questions
PT0511 - PAQ Therapeutics
PT0253 - PAQ Therapeutics
https://www.prnewswire.com/news-releases/paq-therapeutics-announces-series-b-extension-bringing-total-series-b-financing-to-77-million-first-patient-dosed-in-phase-1-trial-of-pt0511-a-pan-kras-degrader-302666808.html
 
Jan 22, 2026
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious